MEA Self-monitoring Blood Glucose Devices Market Share

Statistics for the 2023 & 2024 MEA Self-monitoring Blood Glucose Devices market share, created by Mordor Intelligence™ Industry Reports. MEA Self-monitoring Blood Glucose Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of MEA Self-monitoring Blood Glucose Devices Industry

The Middle East and African self-monitoring blood glucose devices market is fragmented, with few major manufacturers boasting a global market presence. In contrast, the remaining manufacturers are confined to other local regions.

MEA Self-monitoring Blood Glucose Devices Market Leaders

  1. Platinum Equity (LifeScan)

  2. Abbott Diabetes Care

  3. Ascensia Diabetes Care

  4. ARKRAY Inc.

  5. Roche Diabetes Care

*Disclaimer: Major Players sorted in no particular order

MEA Self-monitoring Blood Glucose Devices Market Concentration

MIDDLE EAST AND AFRICA SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)